New animal models of hepatitis B and C. (Q34282823)

1 August 2017

1 reference

title

New animal models of hepatitis B and C. (English)

1 reference

1 August 2017

1 reference

M A Feitelson

1

1 reference

1 August 2017

J D Larkin

series ordinal

2

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

ILAR Journal

1 reference

1 August 2017

volume

42

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

127-138

1 reference

Transmissible agent in non-A, non-B hepatitis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Expression and replication of hepatitis B virus genome in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Experimental infection of chimpanzees with antihemophilic (factor viii) materials: Recovery of virus-like particles associated with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Flavivirus genome organization, expression, and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

A transgenic mouse model of the chronic hepatitis B surface antigen carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis C viral infection in the immunosuppressed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Resection versus transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis C virus viremia in SCID-->BNX mouse chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis viruses and the safety of blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis C virus structural proteins induce liver cell injury in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis C: the clinical spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Chronic type B hepatitis and the "healthy" HBsAg carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Transgenic expression of hepatitis C virus structural proteins in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Expression of hepatitis C virus envelope proteins in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis B virus transgenic mouse model of chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Role of hepatitis C virus in dual and triple hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Therapy of hepatitis C: overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis B: an important public health issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

The molecular virology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

A virus in Beechey ground squirrels that is related to hepatitis B virus of humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Transgenic mouse expressing a full-length hepatitis C virus cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Immune pathogenesis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatitis C virus core and E2 protein expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Hepatocarcinogenicity of the woodchuck hepatitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Therapy of hepatitis C: alpha interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Acute hepatitis in rats expressing human hepatitis B virus transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Functional inactivation but not structural mutation of p53 causes liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Transmission of hepatitis C virus infection to tree shrews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Human hepatitis B virus and hepatocellular carcinoma I. Experimental infection of tree shrews with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

High-Frequency Transfection and Cytopathology of the Hepatitis B Virus Core Antigen Gene in Human Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.42.2.127

21 January 2018

Identifiers

DOI

10.1093/ILAR.42.2.127

1 reference

1 August 2017

1 reference